Robert L Jerzewski

Title: The Innovative Contributions of Robert L. Jerzewski

Introduction

Robert L. Jerzewski is an accomplished inventor based in East Millstone, NJ, renowned for his contributions to pharmaceutical formulations. With a keen focus on the development of stable and effective medication, Jerzewski's work has significantly impacted the field of drug manufacturing.

Latest Patents

Jerzewski holds a patent for his innovation related to Fosinopril tablet formulations. This patent highlights the preparation of shelf-stable tablets containing fosinopril sodium, achieved by using either sodium stearyl fumarate or hydrogenated vegetable oil as lubricants. These formulations can include conventional excipients such as fillers, binders, and disintegrants, along with the option to incorporate a diuretic. This advancement plays a crucial role in enhancing the stability and efficacy of oral medications.

Career Highlights

Throughout his career, Jerzewski has been associated with E.R. Squibb & Sons, Inc., a prominent company in the pharmaceutical sector. His work there has been instrumental in the development of innovative therapeutic solutions, positioning him as a valuable asset to the organization and the industry at large.

Collaborations

Jerzewski has collaborated with esteemed colleagues, including Thomas M. Wong and Lewis J. Gryziewicz. Their combined expertise and efforts in research and development have further propelled advancements in pharmaceutical formulations, leading to new solutions in medication delivery and effectiveness.

Conclusion

Robert L. Jerzewski's work illustrates the vital role inventors play in advancing healthcare solutions. His innovative approach to Fosinopril tablet formulations not only enhances the quality of pharmaceutical products but also showcases the importance of collaboration in achieving remarkable outcomes within the industry. Jerzewski’s contributions continue to influence and inspire ongoing research in pharmaceutical science.